Your shopping cart is currently empty

L-Dopa precursor-1 (Compound 5a) is the precursor of 18F-L-Dopa. Serving as the core basis for a radiolabeling precursor, L-Dopa precursor-1 facilitates the introduction of non-metal radioactive elements through radiolabeling reactions. This compound can be utilized in studies related to renal denervation (RDN) surgery for refractory hypertension and chronic kidney disease.
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | L-Dopa precursor-1 (Compound 5a) is the precursor of 18F-L-Dopa. Serving as the core basis for a radiolabeling precursor, L-Dopa precursor-1 facilitates the introduction of non-metal radioactive elements through radiolabeling reactions. This compound can be utilized in studies related to renal denervation (RDN) surgery for refractory hypertension and chronic kidney disease. |
| Molecular Weight | 667.6 |
| Formula | C33H54BNO12 |
| Cas No. | 2377146-66-0 |
| Smiles | C([C@H](N(C(OC(C)(C)C)=O)C(OC(C)(C)C)=O)C(OC(C)(C)C)=O)C1=C(C=C(OCOC)C(OCOC)=C1)B2OC(C)(C)C(C)(C)O2 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.